re: isn't it time? yes, for some facts
A little realism on the prospects for these overheated bio plays (not this one in particular) is probably a good thing at the moment. Look at the bio sector run in the US where a lot of penny stocks like Medx have doubled in a few weeks. How many years before a revenue stream from these 100m+ dollar babies? Pain coming soon imo.
